Opioid Rehab Placement — New York City

Three FDA-approved medications treat opioid use disorder: buprenorphine (Suboxone, Sublocade injection), methadone (OTP-only), and naltrexone (Vivitrol injection). All three reduce overdose mortality and improve retention in treatment compared to detox-only approaches. Buprenorphine is now the most commonly used in inpatient settings because it doesn't require an OTP and can be continued at any primary care physician after discharge.

Typical opioid inpatient flow: 5–7 days medical detox and buprenorphine induction → 21–28 days residential rehab with individual and group therapy, dual-diagnosis work, relapse prevention → step-down to PHP/IOP or outpatient MAT with monthly Sublocade or daily Suboxone film → long-term maintenance. Naloxone goes home with everyone at discharge. Family members can also get trained on naloxone use through NYC Health.

Most opioid presentations in NYC in 2025–2026 are fentanyl-involved. Standard heroin-era protocols don't always apply. See our /fentanyl-rehab/ page for the specifics on buprenorphine induction timing with fentanyl, xylazine presentations, and what to look for in a program.

Yes. Opioid use disorder is the single largest SUD benefit utilization category in NY — no preauthorization required at in-network OASAS facilities, and concurrent review blocked first 14 days. Most commercial PPO plans cover detox + inpatient + MAT with copay/deductible only. Call (347) 741-7043.